Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - NET INCOME
Net Income PRPH - ProPhase Labs, Inc.
-16.8 M
LAST VALUE
-91.71%
2 YEAR CAGR
-57.35%
5 YEAR CAGR
-45.47%
10 YEAR CAGR